Related Experiment Videos
Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention
1University of Pennsylvania Medical Center, 614 BRBII/III 421 Curie Blvd., Philadelphia, PA 19104, USA. rader@mail.med.upenn.edu
Insights
Novel therapies targeting high-density lipoprotein (HDL) metabolism are needed to prevent atherosclerotic cardiovascular disease (ASCVD). Understanding HDL pathways offers new therapeutic targets for ASCVD complications.
Area of Science:
- Cardiovascular Medicine
- Metabolic Research
- Pharmacology
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death globally.
- Existing treatments for ASCVD, like cholesterol reduction, are insufficient to eliminate disease complications.
- There is a critical need for innovative therapeutic strategies to prevent acute coronary events and slow atherosclerosis progression.
Purpose of the Study:
- To explore high-density lipoprotein (HDL) metabolism as a potential therapeutic target for ASCVD.
- To identify specific components within HDL metabolism and lipid transport pathways relevant for ASCVD prevention and treatment.
Main Methods:
- Review and discussion of current literature on HDL metabolism.
- Analysis of lipid transport pathways involved in HDL function.
- Identification of potential molecular targets within these pathways.
Main Results:
- High-density lipoprotein (HDL) metabolism presents a promising area for therapeutic intervention in ASCVD.
- Specific elements of HDL metabolism and lipid transport are viable targets for preventing ASCVD progression.
- Targeting HDL pathways could offer novel approaches beyond traditional cholesterol reduction therapies.
Conclusions:
- Modulating high-density lipoprotein (HDL) metabolism holds significant potential for novel ASCVD therapies.
- Further research into HDL pathways can lead to improved prevention and treatment of cardiovascular events.
- Targeting HDL offers a promising avenue to address the unmet needs in managing atherosclerotic cardiovascular disease.
Abstract:
Atherosclerotic cardiovascular disease (ASCVD) is the most common cause of morbidity and mortality in Western societies. Current therapies, such as reduction of plasma cholesterol, significantly reduce, but do not come close to eliminating, the complications of ASCVD. Therefore, novel therapeutic approaches to the prevention of acute coronary events and progression of atherosclerosis are still needed. The complex metabolism of high density lipoproteins represents an attractive potential target for therapeutic intervention. Here, we will discuss those components of the high density lipoprotein metabolism and lipid transport pathways that are potential preventative or therapeutic targets for ASCVD.